Matches in SemOpenAlex for { <https://semopenalex.org/work/W3186811088> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W3186811088 endingPage "407" @default.
- W3186811088 startingPage "399" @default.
- W3186811088 abstract "VISION Max (Ortho Clinical Diagnostics, Raritan, NJ) measures anti-A/B isoagglutinin titres using automated column agglutination technology (CAT). We compared tube test (TT) and CAT of VISION Max comprehensively, including failure mode and effect analysis (FMEA), turnaround time (TAT) and cost, and suggested modified CAT (MCAT).For 100 samples (each 25 for blood type A, B and O with anti-A and anti-B), anti-A/B isoagglutinin titres were measured by TT and CAT (1:2-1:1024 dilution), as well as by MCAT (with agglutination at 1:32 dilution, then perform additional testing from 1:64 to 1:1024). We assessed the agreement and correlation between TT and CAT and compared FMEA (risk priority number [RPN] score), TAT (h:min:sec) and cost (US dollar, US $) among TT, CAT and MCAT.TT and CAT showed overall substantial agreement (k = 0.73) and high correlation (ρ ≥ 0.75) except blood type O with anti-A (ρ = 0.68). Compared with TT, CAT showed lower RPN scores in FMEA and similar TAT and cost (FMEA, 33,700 vs. 184,300; TAT, 15:23:00 vs. 14:26:40; cost, 1377.4 vs. 1312.4, respectively). Regarding FMEA, TAT and cost, MCAT was superior to CAT or TT (43,810; 13:28:00; 899.2, respectively).This is the first multidimensional analysis on VISION Max CAT for measuring anti-A/B isoagglutinin titres. The results of anti-A/B isoagglutinin titres by CAT were comparable with those of TT. MCAT would be a safe, time-saving and cost-effective alternative to TT and CAT in high-volume blood bank laboratories." @default.
- W3186811088 created "2021-08-02" @default.
- W3186811088 creator A5012768920 @default.
- W3186811088 creator A5038032396 @default.
- W3186811088 creator A5050049319 @default.
- W3186811088 creator A5058056637 @default.
- W3186811088 creator A5081416614 @default.
- W3186811088 creator A5083484723 @default.
- W3186811088 creator A5087978214 @default.
- W3186811088 date "2021-07-28" @default.
- W3186811088 modified "2023-09-27" @default.
- W3186811088 title "Comparison between tube test and automated column agglutination technology on VISION Max for anti‐A/B isoagglutinin titres: A multidimensional analysis" @default.
- W3186811088 cites W1493614040 @default.
- W3186811088 cites W1507709468 @default.
- W3186811088 cites W1743046353 @default.
- W3186811088 cites W1998306393 @default.
- W3186811088 cites W2037817472 @default.
- W3186811088 cites W2039784264 @default.
- W3186811088 cites W2042055370 @default.
- W3186811088 cites W2060065995 @default.
- W3186811088 cites W2065360903 @default.
- W3186811088 cites W2105776193 @default.
- W3186811088 cites W2164777277 @default.
- W3186811088 cites W2524360718 @default.
- W3186811088 cites W2565322262 @default.
- W3186811088 cites W2752794817 @default.
- W3186811088 cites W2755024112 @default.
- W3186811088 cites W2888506870 @default.
- W3186811088 cites W2893079562 @default.
- W3186811088 cites W2923267992 @default.
- W3186811088 cites W2942988383 @default.
- W3186811088 cites W2950706776 @default.
- W3186811088 cites W2963278287 @default.
- W3186811088 cites W2997147238 @default.
- W3186811088 cites W2998137988 @default.
- W3186811088 cites W3001470492 @default.
- W3186811088 cites W3005698754 @default.
- W3186811088 cites W3010319797 @default.
- W3186811088 cites W3025591530 @default.
- W3186811088 cites W4238446184 @default.
- W3186811088 doi "https://doi.org/10.1111/vox.13184" @default.
- W3186811088 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34318939" @default.
- W3186811088 hasPublicationYear "2021" @default.
- W3186811088 type Work @default.
- W3186811088 sameAs 3186811088 @default.
- W3186811088 citedByCount "0" @default.
- W3186811088 crossrefType "journal-article" @default.
- W3186811088 hasAuthorship W3186811088A5012768920 @default.
- W3186811088 hasAuthorship W3186811088A5038032396 @default.
- W3186811088 hasAuthorship W3186811088A5050049319 @default.
- W3186811088 hasAuthorship W3186811088A5058056637 @default.
- W3186811088 hasAuthorship W3186811088A5081416614 @default.
- W3186811088 hasAuthorship W3186811088A5083484723 @default.
- W3186811088 hasAuthorship W3186811088A5087978214 @default.
- W3186811088 hasConcept C126322002 @default.
- W3186811088 hasConcept C143508840 @default.
- W3186811088 hasConcept C159654299 @default.
- W3186811088 hasConcept C203014093 @default.
- W3186811088 hasConcept C71924100 @default.
- W3186811088 hasConceptScore W3186811088C126322002 @default.
- W3186811088 hasConceptScore W3186811088C143508840 @default.
- W3186811088 hasConceptScore W3186811088C159654299 @default.
- W3186811088 hasConceptScore W3186811088C203014093 @default.
- W3186811088 hasConceptScore W3186811088C71924100 @default.
- W3186811088 hasIssue "3" @default.
- W3186811088 hasLocation W31868110881 @default.
- W3186811088 hasLocation W31868110882 @default.
- W3186811088 hasOpenAccess W3186811088 @default.
- W3186811088 hasPrimaryLocation W31868110881 @default.
- W3186811088 hasRelatedWork W1529576541 @default.
- W3186811088 hasRelatedWork W1532318145 @default.
- W3186811088 hasRelatedWork W1995617640 @default.
- W3186811088 hasRelatedWork W2026206115 @default.
- W3186811088 hasRelatedWork W2102440256 @default.
- W3186811088 hasRelatedWork W2167449535 @default.
- W3186811088 hasRelatedWork W2519053057 @default.
- W3186811088 hasRelatedWork W2801343089 @default.
- W3186811088 hasRelatedWork W2907567991 @default.
- W3186811088 hasRelatedWork W3164708434 @default.
- W3186811088 hasVolume "117" @default.
- W3186811088 isParatext "false" @default.
- W3186811088 isRetracted "false" @default.
- W3186811088 magId "3186811088" @default.
- W3186811088 workType "article" @default.